YF-VAX 1 dose vials
Ended Awarded
- Contract number
- SPE2DB25FYW33
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $33,403
Award facts
- Contract value 100% obligated
- $33,402.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $33,402.60 by the Defense Logistics Agency for the supply of YF-VAX 1 Dose Vials. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of May 15, 2025, and represents no specific set-aside designation. This award is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, a single-award vehicle valued at $499,999,999 and valid through November 2026. The IDC enables the agency to issue delivery orders for a comprehensive range of pharmaceutical items supporting medical supply needs of military health facilities worldwide.
YF-VAX is a yellow fever vaccine commonly used for military personnel and federal employees deployed to endemic regions. Under the broader SPE2DB contract vehicle, DMS Pharmaceutical Group serves as a critical supplier in the federal pharmaceutical supply chain, distributing prescription drugs, biologics, over-the-counter medications, and medical consumables to Department of Defense healthcare sites. The company's robust portfolio of federal contract awards demonstrates consistent capability in delivering specialized pharmaceutical products, from vaccines and injectables to oncology treatments and specialty medications, positioning it as a key provider supporting military health operations.
Quick answers
Who was awarded contract SPE2DB25FYW33?
SPE2DB25FYW33 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on April 24, 2025.
How much is contract SPE2DB25FYW33 worth?
The government has obligated $33,403 on SPE2DB25FYW33.
Is contract SPE2DB25FYW33 an order under another contract?
Yes. SPE2DB25FYW33 is a delivery order under SPE2DB22D9133, an indefinite delivery contract.
Was contract SPE2DB25FYW33 competed?
The extent of competition for SPE2DB25FYW33 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award